Shanghai is advancing breast cancer treatment with a groundbreaking drug trial for triple-negative breast cancer. Led by Fudan University Shanghai Cancer Center, the study merges traditional chemotherapy with Camrelizumab, an innovative immunotherapy developed in China. But beyond medical breakthroughs, this raises another important discussion—the need for reliable health insurance. For expats living in China, securing …